RECOMBINATE 1000 IU

Χώρα: Ισραήλ

Γλώσσα: Αγγλικά

Πηγή: Ministry of Health

Δραστική ουσία:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Διαθέσιμο από:

TEVA MEDICAL MARKETING LTD.

Φαρμακολογική κατηγορία (ATC):

B02BD02

Φαρμακοτεχνική μορφή:

POWDER FOR SOLUTION FOR INJECTION

Οδός χορήγησης:

I.V

Κατασκευάζεται από:

BAXTER S.A., BELGIUM

Θεραπευτική ομάδα:

COAGULATION FACTOR VIII

Θεραπευτικές ενδείξεις:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Ημερομηνία της άδειας:

2010-07-01